Longitudinal Observational Study of Diabetic Retinopathy Progression in Type 2 Diabetes Patients

This study follows patients with type 2 diabetes over time to track whether and how quickly diabetic retinopathy—damage to the blood vessels in the back of the eye caused by high blood sugar—worsens. The goal is to better understand which patients are at highest risk of vision loss so doctors can intervene earlier. **You may be eligible if...** - You are between 35 and 80 years old and have type 2 diabetes - You have non-proliferative diabetic retinopathy or mild early proliferative disease in your eye (but no severe complications yet) - Your vision is at least 20/40 - Your retinal specialist believes treatment can safely be delayed for at least 6 months **You may NOT be eligible if...** - You have severe fluid or swelling in the center of the retina (central subfield thickness above 400 µm) - You have significant growth of new blood vessels in the eye - You have uncontrolled glaucoma or other significant eye conditions - You have had prior pan-retinal laser or injections into the eye - You have had eye surgery within 6 months Talk to your doctor to see if this trial is right for you.